HomeCompareBSX vs PKG

BSX vs PKG: Dividend Comparison 2026

BSX yields 3.18% · PKG yields 2.39%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 PKG wins by $252.3K in total portfolio value
10 years
BSX
BSX
● Live price
3.18%
Share price
$62.93
Annual div
$2.00
5Y div CAGR
-50%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.2K
Annual income
$0.32
Full BSX calculator →
PKG
PKG
● Live price
2.39%
Share price
$209.04
Annual div
$5.00
5Y div CAGR
56.8%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$272.5K
Annual income
$142,289.75
Full PKG calculator →

Portfolio growth — BSX vs PKG

📍 PKG pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodBSXPKG
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, BSX + PKG cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
BSX pays
PKG pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

BSX
Annual income on $10K today (after 15% tax)
$270.14/yr
After 10yr DRIP, annual income (after tax)
$0.27/yr
PKG
Annual income on $10K today (after 15% tax)
$203.31/yr
After 10yr DRIP, annual income (after tax)
$120,946.29/yr
At 15% tax rate, PKG beats the other by $120,946.02/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of BSX + PKG for your $10,000?

BSX: 50%PKG: 50%
100% PKG50/50100% BSX
Portfolio after 10yr
$146.4K
Annual income
$71,145.04/yr
Blended yield
48.60%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on BSX right now

BSX
Analyst Ratings
2
Strong
38
Buy
3
Hold
Consensus: Buy
Price Target
$108.35
+72.2% upside vs current
Range: $94.00 — $130.00
Altman Z
3.9
Piotroski
7/9
PKG
Analyst Ratings
8
Buy
15
Hold
3
Sell
Consensus: Hold
Price Target
$246.00
+17.7% upside vs current
Range: $233.00 — $270.00
Altman Z
3.7
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

BSX buys
6
PKG buys
0
PoliticianChamberTickerTypeAmountDate
Gilbert Cisneros🏢 House$BSX▲ Buy$1,001 - $15,0002026-02-10
Gilbert Cisneros🏢 House$BSX▲ Buy$1,001 - $15,0002026-01-30
Markwayne Mullin🏛 Senate$BSX▲ Buy$15,001 - $50,0002025-12-29
Markwayne Mullin🏛 Senate$BSX▲ Buy$15,001 - $50,0002025-12-29
Gilbert Cisneros🏢 House$BSX▼ Sell$1,001 - $15,0002025-12-24
John Boozman🏛 Senate$BSX▼ Sell$1,001 - $15,0002025-12-17
John Boozman🏛 Senate$BSX▼ Sell$1,001 - $15,0002025-12-17
Gilbert Cisneros🏢 House$BSX▲ Buy$1,001 - $15,0002025-11-18
Kevin Hern🏢 House$BSX▼ Sell$15,001 - $50,0002025-10-28
Gilbert Cisneros🏢 House$BSX▲ Buy$1,001 - $15,0002025-10-17
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricBSXPKG
Forward yield3.18%2.39%
Annual dividend / share$2.00$5.00
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR-50%56.8%
Portfolio after 10y$20.2K$272.5K
Annual income after 10y$0.32$142,289.75
Total dividends collected$321.00$238.7K
Payment frequencyquarterlyquarterly
SectorHealthcareMaterials
Analyst consensusBuyHold
Analyst price target$108.35$246.00

Year-by-year: BSX vs PKG ($10,000, DRIP)

YearBSX PortfolioBSX Income/yrPKG PortfolioPKG Income/yrGap
1← crossover$10,859$158.91$11,075$375.05$216.00PKG
2$11,700$80.63$12,459$608.69$759.00PKG
3$12,559$40.60$14,335$1,003.45$1.8KPKG
4$13,459$20.36$17,030$1,691.83$3.6KPKG
5$14,411$10.20$21,167$2,945.41$6.8KPKG
6$15,425$5.10$28,014$5,364.93$12.6KPKG
7$16,507$2.55$40,380$10,404.83$23.9KPKG
8$17,664$1.28$65,184$21,977.91$47.5KPKG
9$18,901$0.64$121,738$51,990.93$102.8KPKG
10$20,225$0.32$272,549$142,289.75$252.3KPKG

BSX vs PKG: Complete Analysis 2026

BSXHealthcare

Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various urological and pelvic conditions; implantable cardioverter and implantable cardiac resynchronization therapy defibrillators; pacemakers and implantable cardiac resynchronization therapy pacemakers; and remote patient management systems. It also provides medical technologies to diagnose and treat rate and rhythm disorders of the heart comprising 3-D cardiac mapping and navigation solutions, ablation catheters, diagnostic catheters, mapping catheters, intracardiac ultrasound catheters, delivery sheaths, and other accessories; spinal cord stimulator systems for the management of chronic pain; indirect decompression systems; and deep brain stimulation systems. In addition, the company offers interventional cardiology products, including drug-eluting coronary stent systems used in the treatment of coronary artery disease; percutaneous coronary interventions products to treat atherosclerosis; intravascular catheter-directed ultrasound imaging catheters, fractional flow reserve devices, and systems for use in coronary arteries and heart chambers, as well as various peripheral vessels; and structural heart therapies. Further, it provides stents, balloon catheters, wires, and atherectomy systems to treat arterial diseases; thrombectomy and acoustic pulse thrombolysis systems, wires, and stents to treat venous diseases; and peripheral embolization devices, radioactive microspheres, ablation systems, cryotherapy ablation systems, and micro and drainage catheters to treat cancer. The company was incorporated in 1979 and is headquartered in Marlborough, Massachusetts.

Full BSX Calculator →

PKGMaterials

Packaging Corporation of America manufactures and sells containerboard and corrugated packaging products in the United States. The company operates through Packaging and Paper segments. The Packaging segment offers various containerboard and corrugated packaging products, such as conventional shipping containers used to protect and transport manufactured goods; multi-color boxes and displays that help to merchandise the packaged product in retail locations; and honeycomb protective packaging products, as well as packaging for meat, fresh fruit and vegetables, processed food, beverages, and other industrial and consumer products. This segment sells its corrugated products through a direct sales and marketing organization, independent brokers, and distribution partners. The Paper segment manufactures and sells commodity and specialty papers, as well as communication papers, including cut-size office papers, and printing and converting papers. This segment sells white papers through its sales and marketing organization. Packaging Corporation of America was founded in 1867 and is headquartered in Lake Forest, Illinois.

Full PKG Calculator →
📬

Get this BSX vs PKG comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

BSX vs SCHDBSX vs JEPIBSX vs OBSX vs KOBSX vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.